MedPath

Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the efficacy of probiotics on reducing body fat

Not Applicable
Conditions
one
Registration Number
JPRN-UMIN000047852
Lead Sponsor
KSO Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who have history of serious disease 2) Subjects who regularly undertake medications that affect obesity, hyperlipidemia or lipid metabolism 3) Subjects who cannot stop taking health foods or supplements that affect obesity, hyperlipidemia or lipid metabolism 4) Heavy smokers 5) Subjects who have excessive alcoholic drinks 6) Subjects with serious medication allergy or food allergy 7) Subjects who have metal in the CT scan measurement site due to surgery, etc. 8) Subjects with cardiac pacemakers or implantable cardioverter defibrillators. 9) Subject who is pregnant or under lactation, or who is expected to be pregnant during the study 10) Subjects who are currently participating, or intend to participate during this study period, in other trials involving the testing of other foods or the use of drugs or the application of cosmetics and drugs 11) Subjects who are considered to be inappropriate for this study by the principal investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath